2021 annual financial data

Contineum Therapeutics, Inc. 2021 Operating margin

Contineum Therapeutics, Inc. 2021 operating margin with verified reported value…

Direct answer

Operating margin was Not calculable.

Operating income was -28,647,000 USD and net income was -29,001,000 USD.
Operating cash flow was -26,266,000 USD.

Get free Contineum Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-28,647,000 USD
Net income
-29,001,000 USD
Operating cash flow
-26,266,000 USD